Loading…
Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions
The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these r...
Saved in:
Published in: | Pharmaceuticals (Basel, Switzerland) Switzerland), 2022-07, Vol.15 (8), p.948 |
---|---|
Main Authors: | , , , , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733 |
---|---|
cites | cdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733 |
container_end_page | |
container_issue | 8 |
container_start_page | 948 |
container_title | Pharmaceuticals (Basel, Switzerland) |
container_volume | 15 |
creator | Sánchez-Sancho, Francisco Escolano, Marcos Gaviña, Daniel Csáky, Aurelio G. Sánchez-Roselló, María Díaz-Oltra, Santiago del Pozo, Carlos |
description | The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure. |
doi_str_mv | 10.3390/ph15080948 |
format | article |
fullrecord | <record><control><sourceid>proquest_doaj_</sourceid><recordid>TN_cdi_doaj_primary_oai_doaj_org_article_0e49479b26a845c3b63db2a42b68aad2</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><doaj_id>oai_doaj_org_article_0e49479b26a845c3b63db2a42b68aad2</doaj_id><sourcerecordid>2706272207</sourcerecordid><originalsourceid>FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</originalsourceid><addsrcrecordid>eNpdkd9rFDEQgIMotlZf_AsWfKnFrfmdnT4I9tS2UBCsgm8hm2Rvc-4lZ7In3H_f1CtqfZph5puPYQahlwSfMgb47WYkAncYePcIHRJOedtRrh7_kx-gZ6WsMBaKcPIUHTCJ6wjIQ_T9Zhfn0ZdQmjQ07A1vP4Rx53La7HJYBxfi8TyG9DpF3yxSnE2IIS6bG2uGIU3urDkPyxD9NIV2Cj9888UbO4cUy3P0ZDBT8S_u4xH69unj18Vle_354mrx_rq1nMPcWnDcc2qNcsz2IJnAQ0-B98LxQSjZMSFZB44oAGNA0poDtr6TIKBTjB2hq73XJbPSm7q0yTudTNC_CykvtclzsJPX2HPgCnoqTceFZb1krqeG0152xjhaXe_2rs22X3tnfZyzmR5IH3ZiGPUy_dLACRMEquD4XpDTz60vs16HYut1TPRpWzRVWEmMFcEVffUfukrbHOup7ihJFaVYVepkT9mcSsl--LMMwfru-frv89ktfACfEg</addsrcrecordid><sourcetype>Open Website</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2706272207</pqid></control><display><type>article</type><title>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</title><source>PubMed (Medline)</source><source>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</source><creator>Sánchez-Sancho, Francisco ; Escolano, Marcos ; Gaviña, Daniel ; Csáky, Aurelio G. ; Sánchez-Roselló, María ; Díaz-Oltra, Santiago ; del Pozo, Carlos</creator><creatorcontrib>Sánchez-Sancho, Francisco ; Escolano, Marcos ; Gaviña, Daniel ; Csáky, Aurelio G. ; Sánchez-Roselló, María ; Díaz-Oltra, Santiago ; del Pozo, Carlos</creatorcontrib><description>The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.</description><identifier>ISSN: 1424-8247</identifier><identifier>EISSN: 1424-8247</identifier><identifier>DOI: 10.3390/ph15080948</identifier><identifier>PMID: 36015096</identifier><language>eng</language><publisher>Basel: MDPI AG</publisher><subject>3,4-dihydropyrimidinones ; Acids ; Aldehydes ; Analgesics ; Antihypertensives ; Biginelli ; biological activity ; Cancer ; Catalysis ; Enzymes ; Hydrogen bonds ; multicomponent reactions ; privileged structures ; R&D ; Research & development ; Review ; Solvents</subject><ispartof>Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (8), p.948</ispartof><rights>2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><rights>2022 by the authors. 2022</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</citedby><cites>FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</cites><orcidid>0000-0002-2888-2231 ; 0000-0002-4771-5885</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.proquest.com/docview/2706272207/fulltextPDF?pq-origsite=primo$$EPDF$$P50$$Gproquest$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2706272207?pq-origsite=primo$$EHTML$$P50$$Gproquest$$Hfree_for_read</linktohtml><link.rule.ids>230,314,727,780,784,885,25753,27924,27925,37012,37013,44590,53791,53793,75126</link.rule.ids></links><search><creatorcontrib>Sánchez-Sancho, Francisco</creatorcontrib><creatorcontrib>Escolano, Marcos</creatorcontrib><creatorcontrib>Gaviña, Daniel</creatorcontrib><creatorcontrib>Csáky, Aurelio G.</creatorcontrib><creatorcontrib>Sánchez-Roselló, María</creatorcontrib><creatorcontrib>Díaz-Oltra, Santiago</creatorcontrib><creatorcontrib>del Pozo, Carlos</creatorcontrib><title>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</title><title>Pharmaceuticals (Basel, Switzerland)</title><description>The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.</description><subject>3,4-dihydropyrimidinones</subject><subject>Acids</subject><subject>Aldehydes</subject><subject>Analgesics</subject><subject>Antihypertensives</subject><subject>Biginelli</subject><subject>biological activity</subject><subject>Cancer</subject><subject>Catalysis</subject><subject>Enzymes</subject><subject>Hydrogen bonds</subject><subject>multicomponent reactions</subject><subject>privileged structures</subject><subject>R&D</subject><subject>Research & development</subject><subject>Review</subject><subject>Solvents</subject><issn>1424-8247</issn><issn>1424-8247</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>PIMPY</sourceid><sourceid>DOA</sourceid><recordid>eNpdkd9rFDEQgIMotlZf_AsWfKnFrfmdnT4I9tS2UBCsgm8hm2Rvc-4lZ7In3H_f1CtqfZph5puPYQahlwSfMgb47WYkAncYePcIHRJOedtRrh7_kx-gZ6WsMBaKcPIUHTCJ6wjIQ_T9Zhfn0ZdQmjQ07A1vP4Rx53La7HJYBxfi8TyG9DpF3yxSnE2IIS6bG2uGIU3urDkPyxD9NIV2Cj9888UbO4cUy3P0ZDBT8S_u4xH69unj18Vle_354mrx_rq1nMPcWnDcc2qNcsz2IJnAQ0-B98LxQSjZMSFZB44oAGNA0poDtr6TIKBTjB2hq73XJbPSm7q0yTudTNC_CykvtclzsJPX2HPgCnoqTceFZb1krqeG0152xjhaXe_2rs22X3tnfZyzmR5IH3ZiGPUy_dLACRMEquD4XpDTz60vs16HYut1TPRpWzRVWEmMFcEVffUfukrbHOup7ihJFaVYVepkT9mcSsl--LMMwfru-frv89ktfACfEg</recordid><startdate>20220730</startdate><enddate>20220730</enddate><creator>Sánchez-Sancho, Francisco</creator><creator>Escolano, Marcos</creator><creator>Gaviña, Daniel</creator><creator>Csáky, Aurelio G.</creator><creator>Sánchez-Roselló, María</creator><creator>Díaz-Oltra, Santiago</creator><creator>del Pozo, Carlos</creator><general>MDPI AG</general><general>MDPI</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7XB</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>M2O</scope><scope>MBDVC</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><scope>5PM</scope><scope>DOA</scope><orcidid>https://orcid.org/0000-0002-2888-2231</orcidid><orcidid>https://orcid.org/0000-0002-4771-5885</orcidid></search><sort><creationdate>20220730</creationdate><title>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</title><author>Sánchez-Sancho, Francisco ; Escolano, Marcos ; Gaviña, Daniel ; Csáky, Aurelio G. ; Sánchez-Roselló, María ; Díaz-Oltra, Santiago ; del Pozo, Carlos</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>3,4-dihydropyrimidinones</topic><topic>Acids</topic><topic>Aldehydes</topic><topic>Analgesics</topic><topic>Antihypertensives</topic><topic>Biginelli</topic><topic>biological activity</topic><topic>Cancer</topic><topic>Catalysis</topic><topic>Enzymes</topic><topic>Hydrogen bonds</topic><topic>multicomponent reactions</topic><topic>privileged structures</topic><topic>R&D</topic><topic>Research & development</topic><topic>Review</topic><topic>Solvents</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Sánchez-Sancho, Francisco</creatorcontrib><creatorcontrib>Escolano, Marcos</creatorcontrib><creatorcontrib>Gaviña, Daniel</creatorcontrib><creatorcontrib>Csáky, Aurelio G.</creatorcontrib><creatorcontrib>Sánchez-Roselló, María</creatorcontrib><creatorcontrib>Díaz-Oltra, Santiago</creatorcontrib><creatorcontrib>del Pozo, Carlos</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni)</collection><collection>ProQuest Central</collection><collection>ProQuest Central Essentials</collection><collection>AUTh Library subscriptions: ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>ProQuest research library</collection><collection>Research Library (Corporate)</collection><collection>Publicly Available Content Database (Proquest) (PQ_SDU_P3)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><collection>Directory of Open Access Journals</collection><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Sánchez-Sancho, Francisco</au><au>Escolano, Marcos</au><au>Gaviña, Daniel</au><au>Csáky, Aurelio G.</au><au>Sánchez-Roselló, María</au><au>Díaz-Oltra, Santiago</au><au>del Pozo, Carlos</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions</atitle><jtitle>Pharmaceuticals (Basel, Switzerland)</jtitle><date>2022-07-30</date><risdate>2022</risdate><volume>15</volume><issue>8</issue><spage>948</spage><pages>948-</pages><issn>1424-8247</issn><eissn>1424-8247</eissn><abstract>The interest in 3,4-dihydropyrimidine-2(1H)-(thio)ones is increasing every day, mainly due to their paramount biological relevance. The Biginelli reaction is the classical approach to reaching these scaffolds, although the product diversity suffers from some limitations. In order to overcome these restrictions, two main approaches have been devised. The first one involves the modification of the conventional components of the Biginelli reaction and the second one refers to the postmodification of the Biginelli products. Both strategies have been extensively revised in this manuscript. Regarding the first one, initially, the modification of one of the components was covered. Although examples of modifications of the three of them were described, by far the modification of the keto ester counterpart was the most popular approach, and a wide variety of different enolizable carbonylic compounds were used; moreover, changes in two or the three components were also described, broadening the substitution of the final dihydropyrimidines. Together with these modifications, the use of Biginelli adducts as a starting point for further modification was also a very useful strategy to decorate the final heterocyclic structure.</abstract><cop>Basel</cop><pub>MDPI AG</pub><pmid>36015096</pmid><doi>10.3390/ph15080948</doi><orcidid>https://orcid.org/0000-0002-2888-2231</orcidid><orcidid>https://orcid.org/0000-0002-4771-5885</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1424-8247 |
ispartof | Pharmaceuticals (Basel, Switzerland), 2022-07, Vol.15 (8), p.948 |
issn | 1424-8247 1424-8247 |
language | eng |
recordid | cdi_doaj_primary_oai_doaj_org_article_0e49479b26a845c3b63db2a42b68aad2 |
source | PubMed (Medline); Publicly Available Content Database (Proquest) (PQ_SDU_P3) |
subjects | 3,4-dihydropyrimidinones Acids Aldehydes Analgesics Antihypertensives Biginelli biological activity Cancer Catalysis Enzymes Hydrogen bonds multicomponent reactions privileged structures R&D Research & development Review Solvents |
title | Synthesis of 3,4-Dihydropyrimidin(thio)one Containing Scaffold: Biginelli-like Reactions |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-26T03%3A16%3A44IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_doaj_&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Synthesis%20of%203,4-Dihydropyrimidin(thio)one%20Containing%20Scaffold:%20Biginelli-like%20Reactions&rft.jtitle=Pharmaceuticals%20(Basel,%20Switzerland)&rft.au=S%C3%A1nchez-Sancho,%20Francisco&rft.date=2022-07-30&rft.volume=15&rft.issue=8&rft.spage=948&rft.pages=948-&rft.issn=1424-8247&rft.eissn=1424-8247&rft_id=info:doi/10.3390/ph15080948&rft_dat=%3Cproquest_doaj_%3E2706272207%3C/proquest_doaj_%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c449t-c9d4e42ca7d3cb96350fb294b5d4f5768356389d1799aa96289d90ce869598733%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=2706272207&rft_id=info:pmid/36015096&rfr_iscdi=true |